| Primary |
| Hypertension |
50.0% |
| Product Used For Unknown Indication |
29.2% |
| Blood Pressure Increased |
4.2% |
| Depression |
4.2% |
| Erectile Dysfunction |
4.2% |
| Gastrooesophageal Reflux Disease |
4.2% |
| Vertebral Artery Dissection |
4.2% |
|
| Drug Interaction |
20.0% |
| International Normalised Ratio Abnormal |
10.0% |
| Liver Injury |
10.0% |
| Musculoskeletal Pain |
10.0% |
| Orthostatic Hypotension |
10.0% |
| Paraesthesia |
10.0% |
| Renal Disorder |
10.0% |
| Vomiting |
10.0% |
| Weight Decreased |
10.0% |
|
| Secondary |
| Hypertension |
29.5% |
| Product Used For Unknown Indication |
18.2% |
| Drug Use For Unknown Indication |
9.1% |
| Ascites |
4.5% |
| Atrial Fibrillation |
4.5% |
| Actinic Keratosis |
2.3% |
| Aortic Aneurysm |
2.3% |
| Blood Pressure High |
2.3% |
| Blood Pressure Increased |
2.3% |
| Breast Cancer |
2.3% |
| Cardiac Disorder |
2.3% |
| Cerebrovascular Disorder |
2.3% |
| Diverticulum |
2.3% |
| Flushing |
2.3% |
| Gait Disturbance |
2.3% |
| Heart Rate Irregular |
2.3% |
| Myalgia |
2.3% |
| Neuropathy Peripheral |
2.3% |
| Plasma Cell Myeloma |
2.3% |
| Type Iia Hyperlipidaemia |
2.3% |
|
| Vomiting |
9.5% |
| Altered State Of Consciousness |
4.8% |
| Blood Pressure Increased |
4.8% |
| Cutaneous Vasculitis |
4.8% |
| Exposure Via Ingestion |
4.8% |
| Headache |
4.8% |
| Hepatic Enzyme Increased |
4.8% |
| Nausea |
4.8% |
| Palpitations |
4.8% |
| Pruritus |
4.8% |
| Quality Of Life Decreased |
4.8% |
| Rash Generalised |
4.8% |
| Renal Failure Acute |
4.8% |
| Thoracic Vertebral Fracture |
4.8% |
| Throat Irritation |
4.8% |
| Thrombosis |
4.8% |
| Toxicity To Various Agents |
4.8% |
| Transient Ischaemic Attack |
4.8% |
| Viith Nerve Paralysis |
4.8% |
| Weight Increased |
4.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.4% |
| Plasma Cell Myeloma |
9.7% |
| Type 2 Diabetes Mellitus |
7.4% |
| Anxiety |
6.3% |
| Multiple Sclerosis |
6.3% |
| Blood Cholesterol Increased |
5.7% |
| Depression |
5.7% |
| Osteoporosis |
4.6% |
| Chronic Myeloid Leukaemia |
4.0% |
| Diffuse Large B-cell Lymphoma |
3.4% |
| Fabry's Disease |
3.4% |
| Hepatitis C |
3.4% |
| Drug Use For Unknown Indication |
2.9% |
| Non-small Cell Lung Cancer |
2.9% |
| Peripheral T-cell Lymphoma Unspecified |
2.9% |
| Renal Transplant |
2.9% |
| Chronic Lymphocytic Leukaemia |
2.3% |
| Diabetes Mellitus |
2.3% |
| Hypertension |
2.3% |
| Nephrogenic Anaemia |
2.3% |
|
| Vomiting |
16.7% |
| Rash |
10.0% |
| Pneumonia |
6.7% |
| Pruritus |
6.7% |
| Insomnia |
5.0% |
| Pain In Extremity |
5.0% |
| Paraesthesia |
5.0% |
| Visual Impairment |
5.0% |
| Cough |
3.3% |
| Dyspnoea |
3.3% |
| Femur Fracture |
3.3% |
| Full Blood Count Decreased |
3.3% |
| Gait Disturbance |
3.3% |
| Herpes Zoster |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Myalgia |
3.3% |
| Pancreatitis |
3.3% |
| Pancreatitis Acute |
3.3% |
| Pancytopenia |
3.3% |
| Rash Pruritic |
3.3% |
|
